Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.44 USD | -5.72% | -14.08% | +28.27% |
Mar. 18 | Transcript : Lantern Pharma Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 18 | Lantern Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.27% | 61.98M | |
-1.69% | 41.35B | |
+42.15% | 40.38B | |
+3.16% | 39.05B | |
-12.11% | 26.67B | |
+1.89% | 24.07B | |
-23.74% | 18.36B | |
-3.67% | 11.68B | |
+21.18% | 11.6B | |
+7.45% | 11.15B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma : Prices $60 Million Public Offering